06.12.2022 - WALTHAM, Mass., Dec. 06, 2022 (GLOBE NEWSWIRE) - Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical company on a mission to protect humanity from serious viral respiratory diseases, today announced the appointment of Jeremy Gowler as ... Seite 1